Join a COVID-19 Clinical Trial in Tampa – Get Paid & Help Advance Medical Research
COVID-19 clinical trials in Tampa test new treatments and vaccines with the help of volunteer participants. By joining a COVID-19 clinical trial, you'll receive expert health care, financial compensation, and contribute to global health research. Located in Tampa, FL – Santos Research Center is enrolling participants now.
📍 5927 Webb Rd, Tampa, FL 33615 · 📞 (813) 249-9100
Located in Tampa, FL — Santos Research Center is enrolling participants now.
Current COVID-19 Clinical Trials at Santos Research Center in Tampa
COVID-19 Treatment Study – Phase 2
Efforts are underway worldwide to continue developing safe and innovative treatments and vaccines to protect people against the virus that causes COVID-19. Purpose: Evaluating an investigational treatment for individuals recently diagnosed with COVID-19 to reduce symptoms and prevent severe complications.
Study-related phone and in-clinic visits with Physician at no cost.
✔ Accepting New Patients
Study Details
- Start Date: June 2021
- Phase: Phase 2
- Study Type: Interventional
- Duration: 7 Visits
- Insurance: No insurance is needed
- Benefits: Compensation up to $1,500 for time and travel
Eligibility
- Participant ≥ 18 years of age
- Confirmed SARS-CoV-2 infection as determined by RT-PCR
- Initial onset of signs/symptoms attributable to COVID-19 within 5 days
- Has at least 1 medical condition
Exclusions
- History of hospitalization
- Known medical history of active liver disease
- Known HIV infection
- Prior to the current disease episode, any confirmed SARS-CoV-2 infection
COVID-19 Rebound Study – Phase 2
The treatments available today were made possible through the dedicated efforts of thousands of professionals and participants who have joined clinical trials. Purpose: Investigating treatments for COVID-19 symptom rebound after completing a 5-day course of nirmatrelvir / ritonavir (Paxlovid).
Study-related phone and in-clinic visits with Physician at no cost.
✔ Accepting New Patients
Study Details
- Start Date: June 2021
- Phase: Phase 2
- Study Type: Interventional
- Duration: 7 Visits
- Insurance: No insurance is needed
- Benefits: Compensation up to $1,500 for time and travel
Eligibility
- Participant ≥ 18 years of age
- Confirmed SARS-CoV-2 infection as determined by RT-PCR
- Initial onset of signs/symptoms attributable to COVID-19 within 5 days
- Has at least 1 medical condition
Exclusions
- History of hospitalization
- Known medical history of active liver disease
- Known HIV infection
- Prior to the current disease episode, any confirmed SARS-CoV-2 infection
Join Paid Clinical Trials Today
Call today to learn more about joining a paid clinical trial in Tampa!
Why Participate in a COVID-19 Clinical Trial?
- Earn Up to $1,600 for time and travel.
- No Insurance Needed – Study-related medical care is provided at no cost.
- Early access to investigational treatments that could improve COVID-19 care.
- Convenient Tampa Location – Easily accessible for local participants.
- Bilingual staff provide support in English and Spanish.
What to Expect from Our Tampa-Based COVID-19 Clinical Trials
Pre-Screening
Quick health assessment to determine eligibility.
Treatment Phase
Receive investigational medication under expert care.
Follow-Up Care
Monitor symptoms and ensure safety.
Get Compensated Up to $1,600!
Ready to get started? Contact us at (813) 249-9100 or email info@santosresearch.com to begin your pre-screening.
Why Choose Santos Research Center?
COVID-19 clinical trials in Tampa are led by Santos Research Center, a trusted medical research facility committed to advancing medicine. Participants choose us because:
- Experienced Research Team – Conducting COVID-19 clinical trials since 2021.
- Advanced Technology – Cutting-edge medical equipment ensures reliable results.
- Expert Medical Staff – Specialists in infectious disease research provide top-tier care.
- No Cost + Compensation – All study-related medical visits are free, and participants are paid.
- Bilingual Support – English and Spanish-speaking staff create a welcoming environment.
How to Join a COVID-19 Clinical Trial in Tampa
Contact us today to begin your pre-screening process and see if you qualify.
- Call Us Today: Contact us at (813) 249-9100 to schedule a pre-screening.
- Email: Reach out via info@santosresearch.com to request more information.
- Visit Us: Our facility is located at 5927 Webb Rd, Tampa, FL 33615.
Located in Tampa, FL, with easy access for participants across the region.
Join Paid Clinical Trials Today
Join a clinical trial today to make a difference in Covid-19 research. Call (813) 249-9100.
Join a COVID-19 Paid Clinical Trial
Help advance COVID-19 treatment research while receiving expert medical care and compensation. Clinical trials play a vital role in developing new antiviral medications, monoclonal antibodies, and vaccines to improve global health.
Your participation supports FDA-approved research and ensures new treatments are safe and effective.
Frequently Asked Questions: COVID-19 Paid Clinical Trials
What is a COVID-19 Clinical Trial and How Does It Work?
A COVID-19 clinical trial is a type of medical research designed to test the safety, efficacy, and potential side effects of new medications, therapies, or vaccines for COVID-19. These studies are conducted under strict protocols and guidelines set by the Food and Drug Administration (FDA) and Institutional Review Boards (IRBs) to protect patient health.
COVID-19 trials may involve testing small molecule treatments, monoclonal antibody therapies, protease inhibitors, or new vaccines developed by pharmaceutical companies such as Moderna. Some studies also evaluate expanded access programs for patients who do not qualify for standard trials.
For more details, read our guide to clinical trial phases.
COVID-19 trials may involve testing small molecule treatments, monoclonal antibody therapies, protease inhibitors, or new vaccines developed by pharmaceutical companies such as Moderna. Some studies also evaluate expanded access programs for patients who do not qualify for standard trials.
For more details, read our guide to clinical trial phases.
How Does a Randomized Controlled Trial (RCT) Work?
A randomized controlled trial (RCT) is a clinical research method used to test new treatments fairly. Participants are randomly placed into one of two groups: One receives the investigational drug, vaccine, or therapy, while the other receives a placebo, an inactive substance with no medical effect.
This process helps scientists compare results and see if the treatment really works. Many COVID-19 trials, including those testing new antiviral drugs and monoclonal antibodies, use RCTs to measure effectiveness while avoiding bias.
This process helps scientists compare results and see if the treatment really works. Many COVID-19 trials, including those testing new antiviral drugs and monoclonal antibodies, use RCTs to measure effectiveness while avoiding bias.
What is the Role of a Principal Investigator in a Clinical Trial?
A principal investigator (PI) is the lead physician or scientist responsible for overseeing a clinical trial. They ensure that the study follows the approved protocol, safety guidelines, and FDA regulations. The research team, including physicians, nurses, and healthcare providers, works under the PI’s supervision to monitor participants, collect blood samples for pharmacokinetics studies, and track data using electronic health records (EHRs).
Are COVID-19 Clinical Trials Safe?
Yes. All COVID-19 trials at Santos Research Center follow strict Food and Drug Administration, National Institutes of Health, and Institutional Review Board regulations to protect participant safety.
Participants undergo routine health screenings and medical monitoring to track any side effects.
Common safety measures include:
For more details, learn about how clinical trials ensure safety.
Participants undergo routine health screenings and medical monitoring to track any side effects.
Common safety measures include:
- Regular check-ups with physicians to monitor progress
- Continuous health assessments to ensure no severe side effects
- Immediate medical attention if complications arise
For more details, learn about how clinical trials ensure safety.
How to Enroll in a COVID-19 Clinical Trial in Florida
Enrolling in a COVID-19 clinical trial is simple:
- Call (813) 249-9100 to discuss eligibility with a healthcare provider.
- Send an email to info@santosresearch.com to request more information.
- Visit Santos Research Center in Tampa, Florida for a pre-screening evaluation.
What Types of COVID-19 Treatments Are Being Tested?
Current COVID-19 clinical trials at Santos Research Center are investigating:
Learn more about COVID-19 treatment trials in Tampa.
- Antiviral medications (e.g., Remdesivir, Ensitrelvir) to block virus
- Monoclonal antibody therapies to boost the immune response.
- Protease inhibitors are medicines that stop the virus from making copies of itself, helping to prevent the illness from getting worse.
- Experimental vaccines and booster shots designed to improve long-term protection.
Learn more about COVID-19 treatment trials in Tampa.
What is a Placebo, and Why is It Used in Clinical Trials?
A placebo is a harmless, inactive substance that allows researchers to compare its effects against the actual treatment. Placebos help determine whether the investigational drug or therapy is truly effective. Not all trials use placebos, particularly if withholding treatment would pose a health risk to participants.
Can I Participate If I Am Pregnant or Have an Underlying Condition?
Eligibility depends on the trial:
- Some studies exclude pregnant or nursing participants for safety.
- Others specifically study COVID-19 vaccines and treatments in pregnant individuals.
- If you have a pre-existing condition (e.g., heart disease, lung disease, or immune disorders), eligibility will be determined by the trial protocol.
What Happens After the Clinical Trial Ends?
Once a trial is completed, researchers analyze participant data to assess:
- Safety and efficacy of the treatment
- How well the drug or vaccine works in different populations
- Potential approval for public use if results are positive
- Findings are published in scientific journals and submitted to the FDA and NIH for further evaluation
What is the difference between COVID-19 and SARS?
COVID-19 is caused by the SARS-CoV-2 virus, which is part of the coronavirus family. The original SARS virus (SARS-CoV-1) emerged in 2002, causing severe respiratory illness. While both viruses affect the lungs and immune system, COVID-19 has had a broader global impact due to its higher transmission rate during the pandemic.
What are the risks of severe COVID-19?
Some patients experience mild symptoms, while others develop severe complications such as lung inflammation, shortness of breath, blood clots, and heart complications. Individuals with pre-existing conditions (such as heart disease, pregnancy, or immune disorders) have a higher risk of severe illness and hospitalization.
How does the immune system respond to COVID-19?
When infected, the immune system produces antibodies and triggers cytokines to fight the virus. However, some patients experience cytokine storms, which can lead to organ damage, inflammation, and respiratory failure requiring oxygen support or mechanical ventilation.
What are monoclonal antibody therapies, and how do they help COVID-19 patients?
Monoclonal antibodies are special lab-made proteins that act like the body’s natural defenses to fight off the COVID-19 virus. These therapies, like those developed by Moderna and the National Institutes of Health (NIH), have been used for high-risk patients to prevent severe COVID-19.
What are the latest antiviral medications for COVID-19?
Several antiviral medications have been developed to reduce the severity of COVID-19, including:
- Remdesivir – An FDA-approved drug that blocks virus replication.
- Ensitrelvir – A newer protease inhibitor under clinical evaluation.
- Small molecule inhibitors – Target viral proteins to prevent disease.
How does Remdesivir work against COVID-19?
Remdesivir is an antiviral medication that interferes with viral RNA replication, helping hospitalized patients recover faster. It is typically administered through an intravenous (IV) dose in a hospital setting.
Join a COVID-19 Clinical Trial in Tampa
Receive expert medical care and compensation while helping advance COVID-19 research. Call (813) 249-9100 to enroll.